{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:00:49Z","timestamp":1785308449342,"version":"3.55.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunoglobulin G (IgG) subclasses have been documented to have a close association with pemphigus. Nevertheless, the relationship among IgG subclasses, anti-desmoglein (anti-Dsg) autoantibodies, and disease activity remains ambiguous, and their potential utility in monitoring disease progression has yet to be fully clarified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to unravel the associations among IgG subclasses, autoantibodies, and disease activity, thereby offering specific serological evidence to facilitate accurate disease assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Confirmed pemphigus patients (n=183) and healthy controls (n=38) were enrolled. Chemiluminescent immunoassay (CLIA) was used to measure serum levels of IgG1, IgG2, IgG3 and IgG4 in all participants. For pemphigus patients, the levels of anti-Dsg1 and Dsg3 autoantibodies were detected using enzyme-linked immunosorbent assay (ELISA). The correlations of IgG subclasses with anti-Dsg1 and Dsg3 autoantibodies, and pemphigus disease area index (PDAI) were evaluated in different disease stages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, pemphigus patients showed significantly lower levels of IgG3 and IgG4 (\n                      <jats:italic>P =<\/jats:italic>\n                      0.022 and\n                      <jats:italic>P =<\/jats:italic>\n                      0.040, respectively) compared with healthy controls. IgG subclasses exhibited a notable correlation with autoantibody levels, particularly during treatment. In patients with single positivity for anti-Dsg1, all IgG subclasses were lower in the remission group than in the healthy controls and active group. In contrast, among patients with double positivity for anti-Dsg1\/3, IgG3 levels were significantly lower in the remission group. In patients with single positivity for anti-Dsg3, IgG2 levels differed markedly between the active group and the other groups. Receiver operating characteristic (ROC) curve identified an IgG2 cutoff of 5224 (AUC\u00a0=\u00a00.7277) for anti-Dsg3 single-positive patients and an IgG3 cutoff of 189 (AUC\u00a0=\u00a00.7596) for anti-Dsg1\/Dsg3 double-positive patients to distinguish active and remission pemphigus.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IgG2 and IgG3 may serve as valuable adjunctive markers to existing assays for Dsg antibodies. Detection of IgG2 and IgG3 could serve as effective serological tools for judging disease status and facilitating individualized clinical assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1895265","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:03:43Z","timestamp":1785305023000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["IgG subclasses and their significance in pemphigus disease progression monitoring"],"prefix":"10.3389","volume":"17","author":[{"given":"Yi","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Dermatology Hospital of Shandong First Medical University","place":["Jinan, Shandong, China"]},{"name":"Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Dermatology Hospital of Shandong First Medical University","place":["Jinan, Shandong, China"]},{"name":"Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Dermatology Hospital of Shandong First Medical University","place":["Jinan, Shandong, China"]},{"name":"Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Dermatology Hospital of Shandong First Medical University","place":["Jinan, Shandong, China"]},{"name":"Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Dermatology Hospital of Shandong First Medical University","place":["Jinan, Shandong, China"]},{"name":"Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Sang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Dermatology Hospital of Shandong First Medical University","place":["Jinan, Shandong, China"]},{"name":"Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongqi","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Dermatology Hospital of Shandong First Medical University","place":["Jinan, Shandong, China"]},{"name":"Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Dermatology Hospital of Shandong First Medical University","place":["Jinan, Shandong, China"]},{"name":"Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Dermatology Hospital of Shandong First Medical University","place":["Jinan, Shandong, China"]},{"name":"Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Dermatology Hospital of Shandong First Medical University","place":["Jinan, Shandong, China"]},{"name":"Shandong Provincial Institute of Dermatology and Venereology, Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus","volume":"394","author":"Schmidt","year":"2019","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2021.1945925","article-title":"Current status and prospects for the diagnosis of pemphigus vulgaris","volume":"17","author":"Nili","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-018-8986-7","article-title":"Pemphigus group: overview, epidemiology, mortality, and comorbidities","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2340\/0001555562491496","article-title":"Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 1969 and 1978","volume":"62","author":"Hietanen","year":"1982","journal-title":"Acta Derm Venereol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(74)90365-x","article-title":"Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion","volume":"38","author":"Pisanti","year":"1974","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2706","article-title":"Pemphigus vulgaris and pemphigus foliaceus: differences in epidemiology and mortality","volume":"97","author":"Kridin","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.06.055","article-title":"Remarkable differences in the epidemiology of pemphigus among two ethnic populations in the same geographic region","volume":"75","author":"Kridin","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJM200007063430104","article-title":"The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research","volume":"343","author":"Warren","year":"2000","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4081\/itjm.2024.1831","article-title":"Association of immunoglobulins and complement levels with pemphigus in patients at the Khartoum Dermatology and Venereal Disease Hospital, Sudan","volume":"18","author":"Elhag","year":"2024","journal-title":"Ital J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23626","article-title":"The role of IgG4 in systemic lupus erythematosus: implications for pathogenesis and therapy","volume":"38","author":"Liu","year":"2024","journal-title":"J Biochem Mol Toxicol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.03.021","article-title":"Disease associations with isolated elevations of each of the four IgG subclasses","volume":"47","author":"Engelhart","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"B12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13075-022-02792-z","article-title":"Clinical and pathological predictors of relapse in IgG4-related disease","volume":"24","author":"Zongfei","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.10.051","article-title":"Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission","volume":"74","author":"Daneshpazhooh","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02715.x","article-title":"Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission","volume":"22","author":"Kwon","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4317\/jced.56289","article-title":"Evaluation of desmoglein 1 and 3 autoantibodies in pemphigus vulgaris: correlation with disease severity","volume":"12","author":"Delavarian","year":"2020","journal-title":"J Clin Exp Dent"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.9","article-title":"ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus","volume":"145","author":"Abasq","year":"2009","journal-title":"Arch Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.35541\/cjd.20240222","article-title":"Guidelines for diagnosis and treatment of pemphigus in China (2024)","volume":"57","year":"2024","journal-title":"Chin J Dermatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00281-015-0541-1","article-title":"Immune response in pemphigus and beyond: progresses and emerging concepts","volume":"38","author":"Di Zenzo","year":"2016","journal-title":"Semin Immunopathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17505","article-title":"Pemphigus relapse: mechanisms, risk factors, and agents associated with disease recurrence","volume":"51","author":"Pathak","year":"2024","journal-title":"J Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2014.44","article-title":"Human immunoglobulin classes and subclasses show variability in VDJ gene mutation levels","volume":"92","author":"Jackson","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01788","article-title":"The p.Arg435His variation of IgG3 with high affinity to FcRn is associated with susceptibility for pemphigus vulgaris-analysis of four different ethnic cohorts","volume":"9","author":"Recke","year":"2018","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2017.07.012","article-title":"IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid","volume":"88","author":"Dainichi","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2024.152367","article-title":"Diagnosis of autoimmune bullous dermatoses: comparative analysis of immunohistochemical staining using C4d, C3d, IgG, and IgG4 in lesional tissues and perilesional frozen skin samples","volume":"73","author":"Karaba\u011f","year":"2024","journal-title":"Ann Diagn Pathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01477","article-title":"Complement activation in autoimmune bullous dermatoses: a comprehensive review","volume":"10","author":"Edwards","year":"2019","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00403-007-0734-0","article-title":"The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases","volume":"299","author":"Sitaru","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11144.x","article-title":"Enrichment of total serum IgG4 in patients with pemphigus","volume":"167","author":"Funakoshi","year":"2012","journal-title":"Br J Dermatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.849790","article-title":"The diversity of serum anti-DSG3 IgG subclasses has a major impact on pemphigus activity and is predictive of relapses after treatment with rituximab","volume":"13","author":"Golinski","year":"2022","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.11.5239","article-title":"Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity","volume":"92","author":"Bhol","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1713987","article-title":"Clinical correlation of anti-desmoglein antibody dynamics in pemphigus treated with rituximab","volume":"16","author":"Naidu","year":"2025","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1895265\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:03:43Z","timestamp":1785305023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1895265\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2026.1895265"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1895265","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"article-number":"1895265"}}